Open AccessCOMPLEX THERAPY OF ATOPIC CHEILITIS
Author(s) -
N. M. Ilenko,
E. V. Nikolishyna,
I. Yu. Lytovchenko,
Fardin Atash Bar
Publication year - 2021
Publication title -
wiadomości lekarskie
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.133
H-Index - 14
eISSN - 2719-342X
pISSN - 0043-5147
DOI - 10.36740/wlek202102125
Subject(s) - pimecrolimus , medicine , dermatology , antihistamine , atopic dermatitis , physical examination , tacrolimus , surgery , anesthesia , transplantation
The aim: Was to evaluate clinical data after the use of pimecrolimus (1% cream “Elidel”) in patients with mild and moderate severity of atopic cheilitis, according to moderntherapeutic requirements. There was an algorithm of treatment the patients with cheilitis proposed it based on the data from literary sources and personal clinical experience.Materials and methods: 22 patients with atopic cheilitis aged from 19 to 40 agreed on a clinical examination in accordance with the protocol of the study. Patients wereprescribed “Elidel” in the form of 1% cream for lubrication of the affected areas of the skin and lips, and antihistamine “Erius”, for the normalization of the general conditionused sedatives and vitamins after consultation of specialists in the general profile.Results: Patients of both groups during the re-examination after 3, 7, 10 days recorded a positive dynamics of the red border of the lips and skin: a significant reduction in theinflammatory process, normalization of indicators of general blood analysis, improvement in the overall quality of life of patients.Conclusions: The results of treatment allow to consider 1% cream “Elidel” (pimecrolimus) as a preparation of choice in the complex treatment of patients with atopic cheilitisof mild and moderate severity.